Entadamide B

Details

Top
Internal ID ebb8af6b-ea23-4851-a43f-95ca100f1648
Taxonomy Organic nitrogen compounds > Organonitrogen compounds > Amines > Alkanolamines > 1,2-aminoalcohols > N-acylethanolamines
IUPAC Name N-(2-hydroxyethyl)-3,3-bis(methylsulfanyl)propanamide
SMILES (Canonical) CSC(CC(=O)NCCO)SC
SMILES (Isomeric) CSC(CC(=O)NCCO)SC
InChI InChI=1S/C7H15NO2S2/c1-11-7(12-2)5-6(10)8-3-4-9/h7,9H,3-5H2,1-2H3,(H,8,10)
InChI Key YACJUWJRBSAQIG-UHFFFAOYSA-N
Popularity 1 reference in papers

Physical and Chemical Properties

Top
Molecular Formula C7H15NO2S2
Molecular Weight 209.30 g/mol
Exact Mass 209.05442107 g/mol
Topological Polar Surface Area (TPSA) 99.90 Ų
XlogP 0.30
Atomic LogP (AlogP) 0.54
H-Bond Acceptor 4
H-Bond Donor 2
Rotatable Bonds 6

Synonyms

Top
110225-60-0
N-(2-Hydroxyethyl)-3,3-bis(methylthio)propanamide
N-(2-hydroxyethyl)-3,3-bis(methylsulfanyl)propanamide
SCHEMBL10626630
DTXSID00149180
Propanamide, N-(2-hydroethyl)-3,3-bis(methylthio)-

2D Structure

Top
2D Structure of Entadamide B

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9570 95.70%
Caco-2 + 0.5707 57.07%
Blood Brain Barrier + 0.7500 75.00%
Human oral bioavailability - 0.6000 60.00%
Subcellular localzation Mitochondria 0.5442 54.42%
OATP2B1 inhibitior - 0.8480 84.80%
OATP1B1 inhibitior + 0.9483 94.83%
OATP1B3 inhibitior + 0.9476 94.76%
MATE1 inhibitior - 0.9200 92.00%
OCT2 inhibitior - 0.9000 90.00%
BSEP inhibitior - 0.9171 91.71%
P-glycoprotein inhibitior - 0.9333 93.33%
P-glycoprotein substrate - 0.8343 83.43%
CYP3A4 substrate - 0.6042 60.42%
CYP2C9 substrate - 0.6140 61.40%
CYP2D6 substrate - 0.8425 84.25%
CYP3A4 inhibition - 0.9562 95.62%
CYP2C9 inhibition - 0.8459 84.59%
CYP2C19 inhibition - 0.8202 82.02%
CYP2D6 inhibition - 0.9318 93.18%
CYP1A2 inhibition - 0.5451 54.51%
CYP2C8 inhibition - 0.9772 97.72%
CYP inhibitory promiscuity - 0.9639 96.39%
UGT catelyzed + 0.8000 80.00%
Carcinogenicity (binary) - 0.7700 77.00%
Carcinogenicity (trinary) Non-required 0.6750 67.50%
Eye corrosion - 0.8042 80.42%
Eye irritation + 0.6491 64.91%
Skin irritation - 0.7934 79.34%
Skin corrosion - 0.9253 92.53%
Ames mutagenesis - 0.6700 67.00%
Human Ether-a-go-go-Related Gene inhibition - 0.7084 70.84%
Micronuclear - 0.7300 73.00%
Hepatotoxicity - 0.5175 51.75%
skin sensitisation - 0.9134 91.34%
Respiratory toxicity - 0.8222 82.22%
Reproductive toxicity - 0.7333 73.33%
Mitochondrial toxicity - 0.6250 62.50%
Nephrotoxicity + 0.8308 83.08%
Acute Oral Toxicity (c) III 0.6859 68.59%
Estrogen receptor binding - 0.8716 87.16%
Androgen receptor binding - 0.6050 60.50%
Thyroid receptor binding - 0.7610 76.10%
Glucocorticoid receptor binding - 0.9071 90.71%
Aromatase binding - 0.7969 79.69%
PPAR gamma - 0.7682 76.82%
Honey bee toxicity - 0.9114 91.14%
Biodegradation - 0.5500 55.00%
Crustacea aquatic toxicity - 0.7800 78.00%
Fish aquatic toxicity - 0.9214 92.14%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL2581 P07339 Cathepsin D 90.91% 98.95%
CHEMBL3060 Q9Y345 Glycine transporter 2 89.81% 99.17%
CHEMBL4040 P28482 MAP kinase ERK2 89.14% 83.82%
CHEMBL3892 Q99500 Sphingosine 1-phosphate receptor Edg-3 86.55% 97.29%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 86.41% 96.09%
CHEMBL5261 Q7L7X3 Serine/threonine-protein kinase TAO1 86.35% 89.33%
CHEMBL1907591 P30926 Neuronal acetylcholine receptor; alpha4/beta4 82.91% 100.00%
CHEMBL2111367 P27986 PI3-kinase p110-alpha/p85-alpha 81.47% 94.33%
CHEMBL230 P35354 Cyclooxygenase-2 81.26% 89.63%
CHEMBL5701 Q9H2K8 Serine/threonine-protein kinase TAO3 80.16% 96.67%

Cross-Links

Top
PubChem 3035981
NPASS NPC238122
LOTUS LTS0038250
wikiData Q83014889